Medicine and Dentistry
Breast Cancer
83%
Neoplasm
55%
Adipose Tissue
50%
Cancer Cell
50%
Vasculotropin
41%
Transforming Growth Factor Beta
36%
Stromal Cell
33%
Cancer Therapy
29%
Zoledronic Acid
29%
BRCA1
25%
Tumor Microenvironment
25%
Tumor Imaging
25%
Drug Uptake
25%
MCF-7
25%
Gene Mutation
25%
Obesity
25%
Transforming Growth Factor
20%
Metastatic Carcinoma
19%
Bevacizumab
12%
Clinical Trial
12%
Body Mass Index
12%
Tumor Progression
9%
In Vitro
9%
Malignant Neoplasm
8%
Tumor Invasion
8%
Radioactive Tracer
8%
Positron Emission Tomography
8%
Bisphosphonate
6%
Cancer Mortality
5%
Cell Death
5%
Cell Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Vasculotropin
41%
Transforming Growth Factor Beta
38%
Bevacizumab
37%
Breast Cancer
35%
Tumor Microenvironment
28%
Tumor Model
28%
Malignant Neoplasm
27%
Obesity
25%
Transforming Growth Factor Beta Antibody
25%
Fresolimumab
25%
Metastasis
21%
Transforming Growth Factor
20%
Clinical Trial
12%
Tumor Invasion
10%
Tumor Growth
9%
Tracer
8%
Angiogenesis Inhibitor
7%
Trastuzumab
7%
Mouse
7%
Preclinical Study
6%
Cancer Mortality
5%
Keyphrases
Pathway Targeting
25%
Antibody Uptake
25%
Fresolimumab
25%
Breast Cancer Patients
25%
Supernatant
25%
Breast Cancer Cells
25%
Adipose Tissue
25%
ER+ Breast Cancer
25%
MCF-7
25%
Breast Adipose Tissue
25%
Delta Cell
15%
Cell Index
15%
OE19
10%
MCF-7 Cells
10%
Normal Weight
10%
Negative Control
7%
Tumor Delivery
6%
Density Normalization
5%
Antitumor Drug Delivery
5%
Human Esophageal Cancer
5%
Blood Vessel Normalization
5%
Tumor Permeability
5%
Tumor Distribution
5%
XCELLigence
5%
Overweight Patient
5%
Lamellipodia
5%
RPMI-1640
5%
Group Control
5%
Tissue Sampling
5%
Filamentous Actin (F-actin)
5%
